|
1.
|
A JemalR SeigeJ XuE WardCancer statistics,
2010CA Cancer J Clin60277300201010.3322/caac.20073
|
|
2.
|
RA SmithV CokkinidesD BrooksD SaslowM
ShahOW BrawleyCancer screening in the United States, 2011: a review
of current American Cancer Society guidelines and issues in cancer
screeningCA Cancer J Clin61830201110.3322/caac.2009621205832
|
|
3.
|
F Lara-MedinaV Perez-SanchezD
Saavedra-PerezTriple negative breast cancer in Hispanic patients:
high prevalence, poor prognosis, and association with menopausal
status, body mass index, and
parityCancer11736583669201110.1002/cncr.2596121387260
|
|
4.
|
LA CareyCM PerouCA LivasyRace, breast
cancer subtypes, and survival in the Carolina Breast Cancer
StudyJAMA29524922502200610.1001/jama.295.21.249216757721
|
|
5.
|
R DentM TrudeauKI PritchardTriple-negative
breast cancer: clinical features and patterns of recurrenceClin
Cancer Res1344294434200710.1158/1078-0432.CCR-06-304517671126
|
|
6.
|
BG HafftyQ YangM ReissLocoregional relapse
and distant metastasis in conservatively managed triple negative
early-stage breast cancerJ Clin
Oncol2456525657200610.1200/JCO.2006.06.566417116942
|
|
7.
|
EA RakhaME EI-SayedAR GreenAH LeeJF
RobertsonIO EllisPrognostic markers in triple-negative breast
cancerCancer1092532200710.1002/cncr.2238117146782
|
|
8.
|
M TischkowitzJS BrunetLR BeginUse of
immunohistochemical markers can refine prognosis in triple negative
breast cancerBMC Cancer7134200710.1186/1471-2407-7-13417650314
|
|
9.
|
AH WuMC YuCC TsengMC PikeEpidemiology of
soy exposures and breast cancer riskBr J
Cancer98914200810.1038/sj.bjc.660414518182974
|
|
10.
|
AH WuWP KohR WangHP LeeMC YuSoy intake and
breast cancer risk in Singapore Chinese Health StudyBr J
Cancer99196200200810.1038/sj.bjc.660444818594543
|
|
11.
|
SA LeeXO ShuH LiAdolescent and adult soy
food intake and breast cancer risk: results from the Shanghai
Women’s Health StudyAm J Clin Nutr8919201926200919403632
|
|
12.
|
XO ShuY ZhengH CaiK GuZ ChenW ZhengW LuSoy
food intake and breast cancer
survivalJAMA30224372443200910.1001/jama.2009.178319996398
|
|
13.
|
JY DongLQ QinSoy isoflavones consumption
and risk of breast cancer incidence or recurrence: a meta-analysis
of prospective studiesBreast Cancer Res
Treat125315323201110.1007/s10549-010-1270-821113655
|
|
14.
|
Z LiJ LiB MoGenistein induces cell
apoptosis in MDA-MB-231 breast cancer cells via the
mitogen-activated protein kinase pathwayToxicol in
Vitro2217491753200810.1016/j.tiv.2008.08.00118761399
|
|
15.
|
Z LiJ LiB MoGenistein induces G2/M cell
cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231
breast cancer cellsCell Biol
Toxicol24401409200810.1007/s10565-008-9054-118224451
|
|
16.
|
J SpeiserK ForemanE DrinkaNotch-1 and
Notch-4 biomarker expression in triple-negative breast cancerInt J
Surg PatholNov132011(Epub ahead of print).
|
|
17.
|
IeM ShihTL WangNotch signaling,
gamma-secretase inhibitors, and cancer therapyCancer
Res6718791882200710.1158/0008-5472.CAN-06-395817332312
|
|
18.
|
F OswaldS LiptayG AdlerRM SchmidNF-kappaB2
is a putative target gene of activated Notch-l via RBP-JkappaMol
Cell Biol182077208819989528780
|
|
19.
|
S StylianouRB ClarkeK BrennanAberrant
activation of notch signaling in human breast cancerCancer
Res6615171525200610.1158/0008-5472.CAN-05-305416452208
|
|
20.
|
GE GrayRS MannE MitsiadisHuman ligands of
the Notch receptorAm J
Pathol154785794199910.1016/S0002-9440(10)65325-410079256
|
|
21.
|
B GidzinskaNotch1 receptor: structure and
role during T-cell developmentPostepy Hig Med Dosw573693762003(In
Polish).
|
|
22.
|
M ReedijkS OdorcicL ChangHigh-level
coexpression of JAG1 and NOTCH1 is observed in human breast cancer
and is associated with poor overall survivalCancer
Res6585308537200510.1158/0008-5472.CAN-05-106916166334
|
|
23.
|
M ReedijkD PinnaduwageBC DicksonJAG1
expression is associated with a basal phenotype and recurrence in
lymph node-negative breast cancerBreast Cancer Res
Treat111439448200810.1007/s10549-007-9805-317990101
|
|
24.
|
BC DicksonAM MulliganH ZhangG LockwoodFP
O’MalleySE EganM ReedijkHigh-level JAG1 mRNA and protein predict
poor outcome in breast cancerMod
Pathol20685693200710.1038/modpathol.380078517507991
|
|
25.
|
L MieleRational targeting of Notch
signaling in breast cancerExpert Rev Anticancer
Ther811971202200810.1586/14737140.8.8.119718699758
|
|
26.
|
P RizzoH MiaoG D’SouzaCross-talk between
notch and the estrogen receptor in breast cancer suggests novel
therapeutic approachesCancer
Res6852265235200810.1158/0008-5472.CAN-07-574418593923
|
|
27.
|
PC CogswellDC GuttridgeWK FunkhouserAS
Baldwin JrSelective activation of NF-kappa B subunits in human
breast cancer: potential roles for NF-kappa B2/p52 and for
Bcl-3Oncogene1911231131200010.1038/sj.onc.120341210713699
|
|
28.
|
H NakshatriP Bhat-NakshatriDA MartinRJ
Goulet JrGW Sledge JrConstitutive activation of NF-kappaB during
progression of breast cancer to hormone-independent growthMol Cell
Biol173629363919979199297
|
|
29.
|
MA SovakRE BellasDW KimAberrant nuclear
factor-kappaB/Rel expression and the pathogenesis of breast cancerJ
Clin Invest10029522960199710.1172/JCI1198489399940
|
|
30.
|
H NakshatriRJ Goulet JrNF-kappaB and
breast cancerCurr Probl
Cancer26282309200210.1067/mcn.2002.12997712429950
|
|
31.
|
LF ChenW FischleE VerdinWC GreeneDuration
of nuclear NF-kappaB action regulated by reversible
acetylationScience29316531657200110.1126/science.106237411533489
|
|
32.
|
H KawamotoH KoizumiT UchikoshiExpression
of the G2-M checkpoint regulators cyclin B1 and cdc2 in
nonmalignant and malignant human breast lesions: immunocytochemical
and quantitative image analysesAm J Pathol150152319979006317
|
|
33.
|
J YuanR YanA KrämerF EckerdtM RollerM
KaufmannK StrebhardtCyclin B1 depletion inhibits proliferation and
induces apoptosis in human tumor
cellsOncogene2358435852200410.1038/sj.onc.120775715208674
|
|
34.
|
P ViatourM Bentires-AljA ChariotV
DeregowskiL de LevalMP MervilleV BoursNF-kappa B2/p100 induces
Bcl-2
expressionLeukemia1713491356200310.1038/sj.leu.240298212835724
|
|
35.
|
S Luna-MoréS CasqueroA Pérez-MelladoF
RiusB WeillI GornemannImportance of estrogen receptors for the
behavior of invasive micropapillary carcinoma of the breast. Review
of 68 cases with follow-up of 54Pathol Res
Pract1963539200010674270
|
|
36.
|
S WangD YangME LippmanTargeting Bcl-2 and
Bcl-xL with nonpeptidic small-molecule antagonistsSemin
Oncol30133142200310.1053/j.seminoncol.2003.08.01514613034
|
|
37.
|
R LiuC PageDR BeidlerMS WichaG
NúñezOver-expression of Bcl-x(L) promotes chemotherapy resistance
of mammary tumors in a syngeneic mouse modelAm J
Pathol15518611867199910.1016/S0002-9440(10)65505-810595916
|
